Prashasti Sudhakar | Jan 27, 2023, 2:21 PM IST
Union health minister Mansukh Mandaviya and science and technology minister Jitendra Singh launched the intranasal Covid vaccine iNCOVACC developed by Bharat biotech on the occasion of republic day.
India.com News Desk | Jan 26, 2023, 3:39 PM IST
Union Health Minister Mansukh Mandaviya and Science and Technology Minister Jitendra Singh on Thursday launched Bharat Biotech's nasal COVID-19 Made-in-India vaccine iNCOVACC.
India.com News Desk | Dec 28, 2022, 8:20 AM IST
Bharat Biotech's intranasal Covid vaccine Update: "As part of the vaccination programme, CoWIN portal will not accept a fourth dose if a person has already taken a booster dose."
Manmath Nayak | Dec 27, 2022, 3:29 PM IST
Bharat Biotech's intranasal Covid vaccine has been approved by the Union Health Ministry as a booster dose.
India.com News Desk | Dec 27, 2022, 12:07 PM IST
The intra-nasal vaccine would be available at private vaccination centres by the end of January.
Tahir Qureshi | Dec 24, 2022, 3:58 PM IST
To fight the Coronavirus, the government has included Bharat Biotech's nasal vaccine in the vaccination program as a booster dose.
Analiza Pathak | Dec 23, 2022, 10:57 AM IST
Centre Approves Nasal Vaccine Amid BF.7 Sub-variant Fear, Available At Pvt Hospitals From Today
India.com News Desk | Dec 22, 2022, 4:44 PM IST
Nasal Vaccine For COVID-19 Gets Nod in India Amid Omicron BF.7 Variant Scare
India.com News Desk | Aug 13, 2021, 6:54 PM IST
As per the updates, Phase 1 clinical trial has been completed in age groups ranging 18 to 60 years.
India.com Lifestyle Staff | Jun 7, 2021, 8:23 PM IST
A nasal vaccine is given by the nose, rather than a needle through your arm. Nasal spray can provide strong protection against variants of Coronavirus.
IANS | Jan 19, 2021, 9:27 PM IST
Days after getting the DCGI's nod for restricted emergency use of India's first indigenously-made COVID-19 vaccine, Bharat Biotech had applied to the drug regulator for permission to start the clinical trials of their nasal coronavirus vaccine.
PTI | Jan 8, 2021, 8:32 PM IST
Bharat Biotech is focusing on the intranasal vaccine as the existing vaccines require two dose intramuscular injections and a country like India needs 2.6 billion syringes and needles which may add up to pollution.
English
